Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEOSH101 in Androgenetic Alopecia
NCT00418730Phase 2Completed
- Sponsor
- Neosil
- Start
- Jan 2007
- Primary completion
- Oct 2007
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of neosh101 in androgenetic alopecia (AGA), sponsored by Neosil. Started Jan 2007; status: completed.
02
Drugs
neosh101
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT00418730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418730.